| Serial Number | 79334430 |
| Word Mark | U-LOAD |
| Filing Date | Friday, November 12, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 5, 2024 |
| Registration Number | 7318010 |
| Registration Date | Tuesday, March 5, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Preparations for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes, namely, diagnostic preparations for medical purposes and medical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for medical analysis of vaccines, immunotherapeutics and cellular therapies, in particular cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy or other therapy, for medical analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases; diagnostic preparations for analysis for medical purposes, hereunder for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring |
| Pseudo Mark | YOU LOAD |
| Goods and Services | Chemicals used in industry and science, in the nature of immune related chemicals for immune cell analysis, immune cell monitoring, immune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research use, other than medical and veterinary use, and scientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnostic, other than medical and veterinary, purposes, namely, diagnostic reagents and preparations, except for medical or veterinary use; diagnostic kits for scientific and diagnostic, other than medical and veterinary, purposes comprised of diagnostic reagents and preparations, except for medical or veterinary use and also comprised of immune related chemicals used in science, in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non-medical purposes, other than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for use in scientific research in connection with therapy and immunotherapy, in particular, for use in cancer therapy, cancer immunotherapy, for analysis of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; chemical, and diagnostic preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in scientific research in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 25, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Immudex ApS |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | Immudex ApS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Party Name | Immudex ApS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Wednesday, August 24, 2022 | ASSIGNED TO EXAMINER |
| Thursday, February 24, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 1, 2022 | APPLICATION FILING RECEIPT MAILED |
| Thursday, September 1, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, September 2, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, October 27, 2022 | REFUSAL PROCESSED BY MPU |
| Thursday, October 27, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 14, 2022 | REFUSAL PROCESSED BY IB |
| Sunday, April 2, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, April 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 21, 2023 | ASSIGNED TO EXAMINER |
| Thursday, July 20, 2023 | FINAL REFUSAL WRITTEN |
| Thursday, July 20, 2023 | FINAL REFUSAL E-MAILED |
| Thursday, July 20, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, July 26, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, July 26, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, August 14, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, November 8, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, November 8, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 8, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 29, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Monday, December 18, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 5, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 5, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, November 13, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 13, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, November 13, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 6, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |